WPL international gas project turning to lead

Woodside’s Leviathan project off the coast of Israel is under a cloud as its two major joint venture partners look at alternatives.

- Growth or income play

- Questions remain around its international programmes

- First support: $37.30, Second support: $36.63, Resistance: $39.24 

WPL’s partners are looking for alternatives to their preferred method of transport by liquefying the gas for shipment in an LNG format in the form of gas pipelines. The news of pipelines will put WPL into less than favourable terms on a non-binding agreement it signed in December last year, which would see WPL taking a 30% stake and operating an export LNG project.

This change of tact from Noble Energy and Delek Group will put this setup into question and will significantly reduce the internal rate of return WPL will get from the project. It would reduce Woodside's involvement and could lead to the renegotiation of the agreement on less favourable terms.

For a company which is now being accused of being ex-growth, with the giant Pluto project complete and the Browse project at James Price Point put on hold, this deal is under even more strain.

WPL’s international expansion has been questioned since it picked up the Leviathan project. Majority shareholder Royal Dutch Shell has several significant assets in the Arab Sea and in the Gulf which has created geo-political tensions with Israel and between the two companies and has led Shell to question its investment in the company.

Shell is a known seller of WPL at $43.00 and $43.50, having exited the stock on the market in 2011 and 2012 at these prices, which does place a very strong cap on appreciation. However this hasn’t stopped WPL breaking out of a long-term resistance level around $38 as income investors pile into the company as the board looks to increase is payout ratio to 85%.

This change of direction has also changed the fundamentals of investors in WPL. We see WPL as an emerging income play considering the revenue stream coming out of Pluto and the plan to upgrade its payout ratio versus its previous rating of a cyclical growth stock developing mass projects.

If the Leviathan project cannot be renegotiated, could the remaining $1.2 billion set aside on the balance sheet for the project be returned to shareholders? If this is the case we will see a break above the resistance level of $39.24 – the two year high. We don’t see that happening in the interim and therefore believe the stock will ease on the news and could test the $37 mark over the coming days if the deal is lost.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.